Alemtuzumab in multiple sclerosis during the COVID-19 pandemic: A mild uncomplicated infection despite intense immunosuppression.
Mult Scler
; 26(10): 1268-1269, 2020 09.
Article
in English
| MEDLINE | ID: covidwho-401624
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Pneumonia, Viral
/
Coronavirus Infections
/
Multiple Sclerosis, Relapsing-Remitting
/
Alemtuzumab
/
Immunosuppressive Agents
/
Lymphopenia
/
Neutropenia
Type of study:
Case report
/
Prognostic study
Topics:
Long Covid
Limits:
Adult
/
Female
/
Humans
Language:
English
Journal:
Mult Scler
Journal subject:
Neurology
Year:
2020
Document Type:
Article
Affiliation country:
1352458520926459
Similar
MEDLINE
...
LILACS
LIS